177Lu-DOTA-lanreotide: A novel tracer as a targeted agent for tumor therapy

Simple item page
dc.contributor.authorBanerjee, S.
dc.contributor.authorDas, T.
dc.contributor.authorChakraborty, S.
dc.contributor.authorSamuel, G.
dc.contributor.authorKorde, A.
dc.contributor.authorSrivastava, S.
dc.contributor.authorVenkatesh, M.
dc.contributor.authorPillai, M. R. A.
dc.date.accessioned2021-01-25T06:49:56Z
dc.date.available2021-01-25T06:49:56Z
dc.date.issued2004
dc.description.divisionRPhDen
dc.format.extent4365 bytes
dc.format.mimetypetext/html
dc.identifier.sourceNuclear Medicine and Biology, 2004. Vol. 31 (6): pp. 753-759en
dc.identifier.urihttp://hdl.handle.net/123456789/21961
dc.language.isoenen
dc.subjectDOTA-lanreotideen
dc.subject177Luen
dc.subjectA-431 cell linesen
dc.subjectTargeted therapyen
dc.title177Lu-DOTA-lanreotide: A novel tracer as a targeted agent for tumor therapyen
dc.typeArticleen

Click here to download

Original bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
0292.htm
Size:
4.26 KB
Format:
Hypertext Markup Language
Download
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.81 KB
Format:
Item-specific license agreed upon to submission
Description:
Download

Collections

2004